The measure is derived from patient responses to the Hip or Knee Decision Quality Instruments. Participants who have a passing knowledge score (60% or higher) and a clear preference for surgery are considered to have met the criteria for an informed, patient-centered decision.
The target population is adult patients who had a primary hip or knee replacement surgery for treatment of hip or knee osteoarthritis.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis
-
1.14 Numerator
The numerator is the number of respondents who have an adequate knowledge score (60% or greater) and a clear preference for surgery.
-
1.15 Denominator
The denominator includes the number of respondents from the target population who have undergone primary knee or hip replacement surgery for treatment of knee or hip osteoarthritis.
-
Exclusions
Respondents who are missing 3 or more knowledge items do not get a total knowledge score and are excluded. Similarly, respondents who do not indicate a preferred treatment are excluded. No other exclusions as long as the respondent has the procedure for the designated condition.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityPatient Experience and Function Fall 2022Initial EndorsementLast Updated
-
StewardSteward Organization EmailSteward Organization Copyright
Copyright holder of the Hip and Knee Decision Quality Instruments used to generate the measure is Massachusetts General Hospital (MGH). MGH makes the survey available for use free of charge under the creative commons license agreement, with the provision it is not modified or sold.
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #2958, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/2958.zip
Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.